Evidence map›Paper›PMID 42411576›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2026

Photothermal-Activable Artificial Macrophage With Amplified Systemic Antibacterial Responses to Combat Primary and Secondary Infection.

Jiangge Li, Sutong Xiao, Shihuan Gao, Mao Wang, Minjia Yuan, Heng Yang, Mohsen Adeli, Shuang Li, Weifeng Zhao, Chong Cheng and 1 more

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jiangge LiCollege of Biomedical Engineering, National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, China.
Sutong XiaoCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu, China.
Shihuan GaoCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu, China.
Mao WangCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu, China.
Minjia YuanCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu, China.
Heng YangCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu, China.
Mohsen AdeliInstitute of Chemistry and Biochemistry, Free University of Berlin, Berlin, Germany.
Shuang LiCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu, China.ORCID https://orcid.org/0000-0001-7414-630X
Weifeng ZhaoCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu, China.ORCID https://orcid.org/0000-0003-2689-0251
Chong ChengCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu, China.ORCID https://orcid.org/0000-0002-6872-2240
Changsheng ZhaoCollege of Biomedical Engineering, National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, China.

Funding

Fundamental Research Funds for the Central UniversitiesLeading Scientists in Fundamental Research of Sichuan Province 2025JDKXJ0004National Key Research and Development Program of China 2024YFE0201200National Natural Science Foundations of China 52373148National Natural Science Foundations of China 52403195National Natural Science Foundations of China 52525311National Natural Science Foundations of China 82561160101Sichuan Science and Technology Program 2024YFHZ0263State Key Laboratory of Synergistic Chem-Bio Synthesis sklscbs202576The open research fund of Suzhou Laboratory SZLAB-1308-2025-TS018
6 · The paper itself

Abstract

The rapid evolution of antibiotic-resistant bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA), poses a critical threat to human healthcare, underscoring the need for antibiotic-free antibacterial strategies that achieve both effective pathogen eradication and sustained protection against reinfection. Here, inspired by the functions of natural macrophages, we report the de novo design of an Ir/TiN-based photothermal-activable artificial macrophage (ITN Art-M) with enhanced systemic antibacterial activity to combat primary and secondary infections caused by antibiotic-resistant bacteria. The experimental studies and theoretical calculations reveal that the ITN Art-M displays spiky topology, robust photothermal properties, and electron-rich Ir-Ti catalytic sites for reactive oxygen species (ROS) production, which can efficiently capture and kill antibiotic-resistant bacteria. Meanwhile, the synthesized ITN Art-M can induce severe bacterial antigen leakage and exposure through synergistic oxidative and hyperthermic stress, thereby potently stimulating systemic antibacterial responses, assisting in the elimination of primary infections and establishing durable defensive surveillance against secondary infections. Notably, ITN Art-M demonstrates superior MRSA eradication and recurrence prevention, offering a potent, intelligent alternative that may surpass conventional antibiotics in combating bacteria and many other pathogenic cells.

Indexed as

Anti-Bacterial AgentsMacrophagesAnimalsHumansInfrared RaysMethicillin-Resistant Staphylococcus aureusMiceReactive Oxygen SpeciesTitaniumAnti-Bacterial AgentsReactive Oxygen SpeciesTitaniumbacterial sterilizationbiocatalytic materialsenzyme‐like materialsnanomedicinestissue regeneration

Identifiers

PMID42411576
PMCPMC13471911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.